netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 20 of 20


Details
UPD Published from Draft Mode
03/11/2023 15:40:40
(LoweryM )
UPD sitematrix Changed from 0 to
03/11/2023 11:00:00
(DavidS )
UPD isDraft Changed from N to Y
03/11/2023 11:00:00
(DavidS )
UPD FurtherInformation Changed from
  • Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE
  • Approved for the treatment of axial spondyloarthritis in line with NICE

 

to
03/11/2023 11:00:00
(DavidS )
UPD Ixekizumab (Taltz®) removal of MSK indication
03/11/2023 11:00:00
(DavidS )
UPD sitematrix Changed from 0 to
23/10/2023 10:56:00
(DavidS )
UPD FurtherInformation Changed from

  • Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE

  • Approved for the treatment of axial spondyloarthritis in line with NICE

to
23/10/2023 10:56:00
(DavidS )
UPD Ixekizumab (Taltz®) updated formatting
23/10/2023 10:56:00
(DavidS )
LDL Link Added : NICE TA718: Ixekizumab for treating axial spondyloarthritis : https://www.nice.org.uk/guidance/ta718
16/12/2021 15:02:36
(DavidS )
UPD sitematrix Changed from 0 to
16/12/2021 15:02:12
(DavidS )
UPD BlueTeq Changed from to N
16/12/2021 15:02:12
(DavidS )
UPD blackTriangle Changed from to N
16/12/2021 15:02:12
(DavidS )
UPD FurtherInformation Changed from
  • Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE
to
  • Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE
16/12/2021 15:02:12
(DavidS )
UPD Ixekizumab (Taltz®) NICE TA718
16/12/2021 15:02:12
(DavidS )
UPD Ixekizumab (Taltz®) approvded
11/08/2017 14:10:06
(LoweryM )
UPD Ixekizumab (Taltz®) updated
09/08/2017 17:37:32
(DavidS )
UPD Ixekizumab (Taltz®) updated
09/08/2017 17:37:20
(DavidS )
UPD Ixekizumab (Taltz®) updated
09/08/2017 17:37:06
(DavidS )
LDL Link Added : NICE TA442 Ixekizumab for treating moderate to severe plaque psoriasis : https://www.nice.org.uk/guidance/ta442
09/08/2017 17:36:49
(DavidS )
ADD Ixekizumab (Taltz®) Build
NICE TA442
09/08/2017 17:36:15
(DavidS )

 

 

netFormulary